메뉴 건너뛰기




Volumn 57, Issue 3, 2011, Pages 322-326

Heparin pharmacovigilance in brazil

Author keywords

Anticoagulants; Drug monitoring; Drug toxicity; Heparin; Product surveillance

Indexed keywords


EID: 79959496480     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0104-4230(11)70067-7     Document Type: Article
Times cited : (10)

References (26)
  • 1
    • 77952635963 scopus 로고    scopus 로고
    • Callenges in the quality of heparin
    • Filho NA. Callenges in the quality of heparin. Rev Bras Hematol Hemoter. 2009;31(5):306-307.
    • (2009) Rev Bras Hematol Hemoter , vol.31 , Issue.5 , pp. 306-307
    • Filho, N.A.1
  • 2
    • 45949086068 scopus 로고    scopus 로고
    • Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • (8th Edition)
    • Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):141S-59S.
    • (2008) Chest , vol.133 , Issue.6 SUPPL
    • Hirsh, J.1    Bauer, K.A.2    Donati, M.B.3    Gould, M.4    Samama, M.M.5    Weitz, J.I.6
  • 3
    • 79959531840 scopus 로고    scopus 로고
    • Drug information for health care professional (USP-DI)
    • Thomson Micromedex
    • Thomson Micromedex. Drug information for health care professional (USP-DI). Thomson Micromedex 2008.
    • (2008) Thomson Micromedex
  • 4
    • 70350316096 scopus 로고    scopus 로고
    • A busca de soluções para o problema das heparinas no mercado nacional
    • Gomes WJ, Braile DM. A busca de soluções para o problema das heparinas no mercado nacional. Rev Bras Cir Cardiovasc. 2009;24(2):3-4.
    • (2009) Rev Bras Cir Cardiovasc , vol.24 , Issue.2 , pp. 3-4
    • Gomes, W.J.1    Braile, D.M.2
  • 5
    • 0035108777 scopus 로고    scopus 로고
    • Bovine spongiform encephalopathi and variant Creutzfeldt-Jacob disease: Background, evolution and current concerns
    • Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathi and variant Creutzfeldt-Jacob disease: background, evolution and current concerns. EID. 2001;7(1):6-16.
    • (2001) EID , vol.7 , Issue.1 , pp. 6-16
    • Brown, P.1    Will, R.G.2    Bradley, R.3    Asher, D.M.4    Detwiler, L.5
  • 7
    • 77951742223 scopus 로고    scopus 로고
    • Changes in the USP heparin monograph and implications for clinicians
    • Smythe MA, Nutescu EA, Wittkowsky AK. Changes in the USP heparin monograph and implications for clinicians. Pharmacotherapy 2010;30(5):428-431.
    • (2010) Pharmacotherapy , vol.30 , Issue.5 , pp. 428-431
    • Smythe, M.A.1    Nutescu, E.A.2    Wittkowsky, A.K.3
  • 8
    • 84866902895 scopus 로고    scopus 로고
    • U.S.Pharmacopeia, USP Heparin Information. US Pharmacopeia 2010. Available from
    • U.S.Pharmacopeia. USP Heparin Information. US Pharmacopeia 2010. Available from: http://www.usp.org/hottopics/heparin.html.
  • 9
    • 53049095938 scopus 로고    scopus 로고
    • Heparin quality control in the Brazilian market: Implications in the cardiovascularsurgery
    • Melo EI, Pereira MS, Cunha RS, Sa MP, Mourao PA. Heparin quality control in the Brazilian market: implications in the cardiovascularsurgery. Rev Bras Cir Cardiovasc. 2008;23(2):169-174.
    • (2008) Rev Bras Cir Cardiovasc , vol.23 , Issue.2 , pp. 169-174
    • Melo, E.I.1    Pereira, M.S.2    Cunha, R.S.3    Sa, M.P.4    Mourao, P.A.5
  • 11
    • 84866904027 scopus 로고    scopus 로고
    • Agência Nacional de Vigilância Sanitária, Agência Nacional de Vigilância Sanitária (Anvisa) 2010. Available from
    • Agência Nacional de Vigilância Sanitária. Banco de dados de produtos registrados das empresas de medicamentos e hemoderivados. Agência Nacional de Vigilância Sanitária (Anvisa) 2010. Available from: http://www7.anvisa.gov.br/datavisa/consulta_produto/Medicamentos/frmConsultaMedicamentos.asp.
    • Banco De Dados De Produtos Registrados Das Empresas De Medicamentos E Hemoderivados
  • 12
    • 79959502385 scopus 로고
    • World Health Organization (WHO), Policy perspectives in medicine. Geneve: WHO
    • World Health Organization (WHO). Pharmacovigilance: ensuring the safe use of medicines. Policy perspectives in medicine. Geneve: WHO; 1994.
    • (1994) Pharmacovigilance: Ensuring the Safe Use of Medicines
  • 14
    • 84866902894 scopus 로고    scopus 로고
    • Agência Nacional de Vigilância Sanitária (Anvisa), Resolução n° 4 de fevereiro de 2009
    • Agência Nacional de Vigilância Sanitária (Anvisa). Resolução n° 4 de fevereiro de 2009.
  • 15
    • 0037321325 scopus 로고    scopus 로고
    • Heparin, lowmolecular- weight heparins, and heparin pentasaccharide: Basic and clinical differentiation
    • Hoppensteadt D, Walenga JM, Fareed J, Bick RL. Heparin, lowmolecular- weight heparins, and heparin pentasaccharide: basic and clinical differentiation. Hematol Oncol Clin North Am. 2003;17(1):313-341.
    • (2003) Hematol Oncol Clin North Am , vol.17 , Issue.1 , pp. 313-341
    • Hoppensteadt, D.1    Walenga, J.M.2    Fareed, J.3    Bick, R.L.4
  • 17
    • 45949103154 scopus 로고    scopus 로고
    • Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • (8th Edition)
    • Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):340S-80S.
    • (2008) Chest , vol.133 , Issue.6 SUPPL
    • Warkentin, T.E.1    Greinacher, A.2    Koster, A.3    Lincoff, A.M.4
  • 18
    • 44949233239 scopus 로고    scopus 로고
    • The FDA and safety-beyond the heparin crisis
    • Laurencin CT, Nair L. The FDA and safety-beyond the heparin crisis. Nat Biotechnol. 2008;26(6):621-623.
    • (2008) Nat Biotechnol , vol.26 , Issue.6 , pp. 621-623
    • Laurencin, C.T.1    Nair, L.2
  • 20
    • 79959495642 scopus 로고    scopus 로고
    • U.S. Pharmacopeia. USP Statement on heparin potency unit assignmentand harmonization with the International Standard for unfractionated heparin
    • U.S. Pharmacopeia. USP Statement on heparin potency unit assignmentand harmonization with the International Standard for unfractionated heparin. 2010.
    • (2010)
  • 21
    • 85088746175 scopus 로고    scopus 로고
    • ® System. Colo: Greenwood Village
    • ® System. Colo: Greenwood Village; 2010.
    • (2010)
  • 22
    • 4644242157 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • Warkentin T E, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):311S-37S.
    • (2004) Chest , vol.126 , Issue.3 SUPPL
    • Warkentin, T.E.1    Greinacher, A.2
  • 23
    • 33645718758 scopus 로고    scopus 로고
    • Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update
    • Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.Thromb Res. 2006;118(2):165-176.
    • (2006) Thromb Res , vol.118 , Issue.2 , pp. 165-176
    • Greinacher, A.1    Warkentin, T.E.2
  • 24
    • 84866899689 scopus 로고    scopus 로고
    • The Uppsala Monitoring Centre (UMC). Frequency of adverse drug reactions, World Health Organization, The Uppsala Monitoring Centre; 2008. Available from
    • The Uppsala Monitoring Centre (UMC). Frequency of adverse drug reactions. 2008. World Health Organization, The Uppsala Monitoring Centre; 2008. Available from: http://www.who-umc.org/Dyn-Page.aspx?id=22684.
    • (2008)
  • 25
    • 51649129542 scopus 로고    scopus 로고
    • The financial impact of heparin-induced thrombocytopenia
    • Smythe MA, Koerber JM, Fitzgerald M, Mattson JC. The financial impact of heparin-induced thrombocytopenia. Chest 2008;134(3):568-73.
    • (2008) Chest , vol.134 , Issue.3 , pp. 568-573
    • Smythe, M.A.1    Koerber, J.M.2    Fitzgerald, M.3    Mattson, J.C.4
  • 26
    • 84866908484 scopus 로고    scopus 로고
    • Notivisa - Sistema de Notificação em Vigilância Sanitária, Brasília (DF): Agência Nacional de Vigilância Sanitária (Anvisa); 2010. Available from
    • Notivisa - Sistema de Notificação em Vigilância Sanitária. 2010. Brasília (DF): Agência Nacional de Vigilância Sanitária (Anvisa); 2010. Available from: http://anvisa.gov.br/hotsite/notivisa/index/htm.
    • (2010)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.